Inventor · disambiguated record
Johannes Petrus Maria Langedijk
Also filed as: LANGEDIJK JOHANNES · LANGEDIJK JOHANNES P M · LANGEDIJK JOHANNES PETRUS M · LANGEDIJK JOHANNES PETRUS MARI
36 granted patents·12 pending applications·128 citations·filing 1995–2023
96Inventor score
Files withJANSSEN VACCINES & PREVENTION BV39JANSSEN PHARMACEUTICALS INC6PEPSCAN SYSTEMS BV2INSTITUUT VOOR DIERHOUDERIJ EN1
Top patents by PatentIndex Score
48 records- 0195US11229694B2Vaccine against RSVJANSSEN VACCINES & PREVENTION BV·Filed 2019·Granted Jan 25, 2022·9 cites·8 claims
- 0294US11338031B2Vaccine against RSVJANSSEN VACCINES & PREVENTION BV·Filed 2020·Granted May 24, 2022·5 cites·18 claims
- 0394US10456462B2Vaccine against RSVJANSSEN VACCINES & PREVENTION BV·Filed 2016·Granted Oct 29, 2019·8 cites·6 claims
- 0493US11498944B2Compositions and methods for preventing and treating coronavirus infection—SARS-CoV-2 vaccinesJANSSEN PHARMACEUTICALS INC·Filed 2021·Granted Nov 15, 2022·10 cites·28 claims
- 0593US10899800B2Stabilized soluble pre-fusion RSV F polypeptidesJANSSEN VACCINES & PREVENTION BV·Filed 2014·Granted Jan 26, 2021·12 cites·38 claims
- 0693US10729757B2Vaccine against RSVJANSSEN VACCINES & PREVENTION BV·Filed 2017·Granted Aug 4, 2020·15 cites·31 claims
- 0791US11384122B2Compositions and methods for preventing and treating coronavirus infection—SARS-CoV-2 vaccinesJANSSEN PHARMACEUTICALS INC·Filed 2021·Granted Jul 12, 2022·2 cites·30 claims
- 0891US11155583B2Stabilized soluble pre-fusion RSV F proteinsJANSSEN VACCINES & PREVENTION BV·Filed 2017·Granted Oct 26, 2021·7 cites·19 claims
- 0991US10953087B2Stabilized pre-fusion RSV F proteinsJANSSEN VACCINES & PREVENTION BV·Filed 2017·Granted Mar 23, 2021·5 cites·32 claims
- 1088US11365222B2Trimer stabilizing HIV envelope protein mutationsJANSSEN VACCINES & PREVENTION BV·Filed 2020·Granted Jun 21, 2022·2 cites·21 claims
- 1188US11034731B2Stabilized soluble pre-fusion RSV F polypeptidesJANSSEN VACCINES & PREVENTION BV·Filed 2019·Granted Jun 15, 2021·5 cites·16 claims
- 1287US10968254B2Trimer stabilizing HIV envelope protein mutationsJANSSEN VACCINES & PREVENTION BV·Filed 2018·Granted Apr 6, 2021·3 cites·22 claims
- 1386US11723970B2Poxvirus vectors encoding HIV antigens, and methods of use thereofJANSSEN VACCINES & PREVENTION BV·Filed 2021·Granted Aug 15, 2023·1 cites·20 claims
- 1485US10457708B2Stabilized soluble pre-fusion RSV F polypeptidesJANSSEN VACCINES & PREVENTION BV·Filed 2016·Granted Oct 29, 2019·3 cites·14 claims
- 1585US10369214B2Synthetic human immunodeficiency virus (HIV) envelope antigen, vectors, and compositions thereofJANSSEN VACCINES & PREVENTION BV·Filed 2016·Granted Aug 6, 2019·5 cites·51 claims
- 1683US10793607B2Trimer stabilizing HIV envelope protein mutationsJANSSEN VACCINES & PREVENTION BV·Filed 2017·Granted Oct 6, 2020·2 cites·23 claims
- 1781US10294279B2Stabilized soluble pre-fusion RSV F polypeptidesJANSSEN VACCINES & PREVENTION BV·Filed 2014·Granted May 21, 2019·5 cites·22 claims
- 1879US7067487B2Transport peptides such as C-terminal Erns peptide and analogues thereofPEPSCAN SYSTEMS BV·Filed 2002·Granted Jun 27, 2006·5 cites·23 claims
- 1978US11229693B2Poxvirus vectors encoding HIV antigens, and methods of use thereofJANSSEN VACCINES & PREVENTION BV·Filed 2018·Granted Jan 25, 2022·1 cites·20 claims
- 2076US11801297B2Vaccine against RSVJANSSEN VACCINES & PREVENTION BV·Filed 2022·Granted Oct 31, 2023·0 cites·1 claims
- 2175US11998597B2Vaccine against RSVJANSSEN VACCINES & PREVENTION BV·Filed 2022·Granted Jun 4, 2024·0 cites·20 claims
- 2275US11820796B2Trimer stabilizing HIV envelope protein mutationsJANSSEN VACCINES & PREVENTION BV·Filed 2022·Granted Nov 21, 2023·0 cites·15 claims
- 2375US2023374078A1Trimer Stabilizing HIV Envelope Protein MutationsJANSSEN VACCINES & PREVENTION BV·Filed 2023·Application pending·0 cites
- 2473US2023265127A1Stabilized soluble pre-fusion rsv f polypeptidesJANSSEN VACCINES & PREVENTION BV·Filed 2022·Application pending·0 cites
- 2571US12234264B2Stabilized soluble pre-fusion RSV F proteinsJANSSEN VACCINES & PREVENTION BV·Filed 2021·Granted Feb 25, 2025·0 cites·8 claims
- 2671US11896663B2Immunodeficiency virus type 1 (HIV-1) mutant envelope proteinsJANSSEN VACCINES & PREVENTION BV·Filed 2021·Granted Feb 13, 2024·0 cites·6 claims
- 2770US11732010B2Trimer stabilizing HIV envelope protein mutationsJANSSEN VACCINES & PREVENTION BV·Filed 2021·Granted Aug 22, 2023·0 cites·15 claims
- 2870US10973907B2Recombinant adenoviruses encoding mosaic human immunodeficiency virus (HIV) Env, Gag, and Pol antigensJANSSEN VACCINES & PREVENTION BV·Filed 2019·Granted Apr 13, 2021·0 cites·15 claims
- 2969US11905314B2Influenza virus vaccines and uses thereofJANSSEN VACCINES & PREVENTION BV·Filed 2022·Granted Feb 20, 2024·0 cites·16 claims
- 3068US11759514B2Stabilized pre-fusion RSV F proteinsJANSSEN VACCINES & PREVENTION BV·Filed 2021·Granted Sep 19, 2023·0 cites·19 claims
- 3166US2021284698A1Stabilized soluble pre-fusion rsv f polypeptidesJANSSEN VACCINES & PREVENTION BV·Filed 2021·Application pending·0 cites
- 3265US2021101940A1Stabilized Soluble Pre-Fusion RSV F PolypeptidesJANSSEN VACCINES & PREVENTION BV·Filed 2020·Application pending·0 cites
- 3364US6077511AAntigenic peptide derived from the G protein of RSV for type- and subtype-specific diagnosis of respiratory syncytial virus (RSV) infectionINSTITUUT VOOR DIERHOUDERIJ EN·Filed 1995·Granted Jun 20, 2000·23 cites·22 claims
- 3460US10711042B2Stabilized viral class I fusion proteinsJANSSEN VACCINES & PREVENTION BV·Filed 2019·Granted Jul 14, 2020·0 cites·25 claims
- 3559US11447526B2Influenza virus vaccines and uses thereofJANSSEN VACCINES & PREVENTION BV·Filed 2019·Granted Sep 20, 2022·0 cites·34 claims
- 3659US7435721B2Transport peptides such as C-terminal Erns peptide and analogues thereofPEPSCAN SYSTEMS BV·Filed 2006·Granted Oct 14, 2008·0 cites·8 claims
- 3758US2022265813A1Trimer Stabilizing HIV Envelope Protein MutationJANSSEN VACCINES & PREVENTION BV·Filed 2022·Application pending·0 cites
- 3857US12331077B2Stabilized pre-fusion RSV F proteinsJANSSEN VACCINES & PREVENTION BV·Filed 2019·Granted Jun 17, 2025·0 cites·17 claims
- 3956US2024197859A1Stabilized Pre-Fusion PIV3 F ProteinsJANSSEN VACCINES & PREVENTION BV·Filed 2022·Application pending·0 cites
- 4055US2024228548A9Stabilized pre-fusion rsv fb antigensJANSSEN VACCINES & PREVENTION BV·Filed 2022·Application pending·0 cites
- 4155US2024189416A1Stabilized coronavirus spike protein fusion proteinsJANSSEN PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4253US2023302119A1Stabilized Corona Virus Spike Protein Fusion ProteinsJANSSEN PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4352US10538557B2Stabilized viral class I fusion proteinsJANSSEN VACCINES & PREVENTION BV·Filed 2016·Granted Jan 21, 2020·0 cites·25 claims
- 4452US2023310573A1Stabilized Vaccine CompositionsJANSSEN VACCINES & PREVENTION BV·Filed 2021·Application pending·0 cites
- 4551US2021346492A1SARS-CoV-2 VaccinesJANSSEN PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4651US2021347828A1RNA Replicon Encoding a Stabilized Corona Virus Spike ProteinJANSSEN PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4746US12454554B2Influenza virus vaccines and uses thereofJANSSEN VACCINES & PREVENTION BV·Filed 2020·Granted Oct 28, 2025·0 cites·25 claims
- 4846US11603390B2Stabilized Filovirus glycoprotein trimersJANSSEN VACCINES & PREVENTION BV·Filed 2019·Granted Mar 14, 2023·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Johannes Petrus Maria Langedijk files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →